TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1 July 15, 1983